ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE | N203414 | TAKEDA PHARMACEUTICALS USA INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
TAKEDA PHARMACEUTICAL COMPANY LTD. et al v. INDOCO REMEDIES LTD. 4 patentsANDA 209998alogliptin benzoate and metformin hydrochloride | D.N.J. | 2018-01-03 | Terminated 2018-03-08 | — |
| D.N.J. | 2017-09-20 | Terminated 2019-11-05 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$2.49
per ea
Lowest NADAC/Unit
$2.20
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 45802021172ALOGLIPTIN-METFORMIN 12.5-1000 | $2.49 | EA | Generic | — | 2026-06-17 |
| 45802016972ALOGLIPTIN-METFORMIN 12.5-500 | $2.20 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.